Madeleine Crabtree, MPH

Broadstreet HEOR, Canada

Disclosure(s): Broadstreet HEOR: employee; ViiV Healthcare: Funding for the conduct of this work

Poster(s):

• (P-576) Real-world Experience with the Two-Drug Regimen Dolutegravir/Lamivudine for the Treatment of HIV-1 among Vulnerable People Living with HIV in Canada: Preliminary Results from a Chart Review Study
  Thursday, October 17, 2024

  12:15 PM – 1:30 PM US PT